Magazine Article | September 1, 2022

Making An Unapprovable Drug Product Approvable

Source: Life Science Leader

By Parrish Galliher

This is the real story of a drug that was in the middle of Phase 3 trials, showing great promise against a fatal neurological disease, and garnering a lot of interest from the FDA regarding the outcome of the trials.

That interest, though, also led to the agency determining that the commercialization potential of the manufacturing process was severely inefficient and making an unsafe drug product. They asked us to think about how we would completely transform the manufacturing process and turn it into a licensable process.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: